HEALTHDAILY MAIL US
Ozempic and Wegovy can lead to devastating muscle and bone loss... now experts reveal exactly how to fight it
Ozempic and Wegovy, GLP-1 receptor agonists, are associated with significant muscle and bone loss in patients. Experts highlight strategies to mitigate these effects, though the side effects remain a major concern.
Related Signal
Adjacent reporting
- Ozempic and Wegovy can lead to devastating muscle and bone loss... now experts reveal exactly how to fight it
- Scientists may have found a way to keep your bones strong for life
- Ozempic face IS real, say scientists as they find weight loss jabs trigger muscle wasting
- Genetic predictors of GLP1 receptor agonist weight loss and side effects
- The hidden tradeoff behind today’s most popular weight loss drugs
- New obesity treatment may help preserve muscle during weight loss